ISDA

Deposition Date 2010-05-24

Release Date 2010-07-07

Last Version Date 2024-10-09

Entry Detail

PDB ID:

2XFK

Keywords:

HYDROLASE

Title:

Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-((methylsulfonyl)(phenyl)amino)benzamide

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Host Organism:

CRICETULUS GRISEUS

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.80 Å

R-Value Free:

0.19

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:BETA-SECRETASE 1
Gene (Uniprot):BACE1
Mutations:YES
Chain IDs:A
Chain Length:392
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P56817 Pfam ID:PF00026 EC:3.4.23.46

Ligand Molecules

AA9

Primary Citation

Bace-1 Inhibitors Using Novel Edge-to-Face Interaction with Arg-296

Clarke, B, Cutler, L, Demont, E, Dingwall, C, Dunsdon, R, Hawkins, J, Howes, C, Hussain, I, Maile, G, Matico, R, Mosley, J, Naylor, A, O'Brien, A, Redshaw, S, Rowland, P, Soleil, V, Smith, K.J, Sweitzer, S, Theobald, P, Vesey, D, Walter, D.S, Wayne, G.Show

Bioorg.Med.Chem.Lett. 20 4639 ? (2010)

PMID: 20579874 DOI: 10.1016/J.BMCL.2010.05.111

Abstact

Inhibition of the aspartyl protease BACE-1 has the potential to deliver a disease-modifying therapy for Alzheimer's disease. Herein, is described a series of potent inhibitors based on an hydroxyethylamine (HEA) transition state mimetic template. These inhibitors interact with the non prime side of the enzyme using a novel edge-to-face interaction with Arg-296.

Legend

Protein

Chemical

Disease

Primary Citation of related structures